MNRI and Recurrent Obstructive Bronchitis: Effects on Immune Function
- Jun 21
- 1 min read
This study examined 60 children ages 2–13 with recurrent obstructive bronchitis, comparing standard medical treatment alone with treatment combined with MNRI® reflex integration therapy. Researchers observed improvements in immune function among children receiving MNRI, including changes in immune markers associated with enhanced regulation and responsiveness. These findings were accompanied by fewer respiratory recurrences and longer periods between illness episodes, suggesting that MNRI may support immune system effectiveness when used alongside standard care.